SyntekaBio, Inc. (KOSDAQ:226330)

SyntekaBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	82,600	59,432	80,107	216,882	115,982	241,650
Market Cap Growth	-21.43%	-25.81%	-63.06%	87.00%	-52.00%	-21.37%
Enterprise Value	73,381	70,195	71,044	189,591	86,513	-
Last Close Price	3405.00	3895.00	4388.79	11904.07	7172.54	14963.68
PS Ratio	24.09	17.33	662.66	1757.47	475.35	763.13
PB Ratio	2.60	1.87	3.21	6.95	3.69	8.75
P/TBV Ratio	2.63	1.89	3.27	7.05	3.76	8.89
EV/Sales Ratio	21.40	20.47	587.69	1536.32	354.57	-
Debt / Equity Ratio	0.22	0.22	0.29	0.07	0.35	0.32
Net Debt / Equity Ratio	-0.29	-0.29	-0.19	-0.56	-0.77	-1.59
Net Debt / EBITDA Ratio	1.06	1.06	0.40	1.67	2.35	5.67
Net Debt / FCF Ratio	0.87	0.87	0.29	1.01	1.43	3.25
Asset Turnover	0.08	0.08	0.00	0.00	0.00	0.01
Quick Ratio	1.41	1.41	0.74	1.02	1.59	28.00
Current Ratio	1.42	1.42	0.77	1.13	1.69	30.82
Return on Equity (ROE)	-61.27%	-61.27%	-25.68%	-36.36%	-15.25%	-42.80%
Return on Assets (ROA)	-14.91%	-14.91%	-18.46%	-14.13%	-11.93%	-9.87%
Return on Capital Employed (ROCE)	-31.40%	-31.40%	-52.10%	-36.60%	-35.30%	-13.50%
Earnings Yield	-21.04%	-29.24%	-9.00%	-5.25%	-3.89%	-6.13%
FCF Yield	-12.91%	-17.94%	-20.24%	-8.04%	-14.57%	-5.59%
Buyback Yield / Dilution	-2.20%	-2.20%	-6.52%	-5.94%	-0.37%	-1.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.